Related Experiment Videos
Gene therapy applications for spine fusion
1Emory Spine Center, Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia 30033, USA.
Spine
|August 5, 2003
Summary
Gene therapy shows promise for enhancing spinal fusion by delivering growth factors. This approach could potentially eliminate autograft use and enable minimally invasive spine surgery.
Area of Science:
- Biotechnology
- Orthopedic Surgery
- Regenerative Medicine
Background:
- Gene therapy involves nucleic acid transfer (RNA or DNA) for disease treatment.
- Its application has expanded beyond genetic defect correction.
- Potential for localized, physiologic delivery of growth factors for spinal fusion is under investigation.
Purpose of the Study:
- Review the use of growth factors for spinal fusion.
- Outline gene therapy principles.
- Discuss gene therapy's application in spinal fusion surgery.
Main Methods:
- Review of existing literature on growth factors and gene therapy.
- Analysis of gene therapy principles relevant to bone induction.
- Evaluation of preclinical animal studies.
Main Results:
- Gene therapy is suitable for spinal fusion due to local application and short transgene response needs.
- Various osteoinductive growth factors are available.
- Successful in vivo and ex vivo gene therapy for spine fusion demonstrated in lower animals.
Conclusions:
- Gene therapy strategies are well-suited for spinal fusion.
- Further testing in non-human primates is needed before human trials.
- Successful gene therapy could eliminate autograft morbidity and enable minimally invasive spine surgery.